Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinomaDaniel Shu, Mark Yarchoan|Nature Immunology|2024Cited by 84
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysisAntonio D’Alessio, David J. Pinato, Julia Blanter et al.|The Lancet Oncology|2024Cited by 64